Related Experiment Video
Updated: May 30, 2026
07:49
Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Increases in mitochondrial biogenesis impair carcinogenesis at multiple levels
1Cancer Biology Graduate Program, University of Miami School of Medicine, Miami, FL 33136, USA.
Molecular Oncology
|August 23, 2011
Summary
Activating mitochondrial biogenesis pathways in cancer cells with bezafibrate decreased proliferation and invasiveness. This study highlights enhancing mitochondrial efficiency as a strategy to impede cancer progression.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Mitochondrial respiration is often decreased in cancer cells, but its role in cancer progression remains unclear.
- Investigating mitochondrial function in cancer requires understanding how alterations impact cellular behavior.
Purpose of the Study:
- To investigate the effects of enhanced mitochondrial biogenesis on cancer cell proliferation and invasiveness.
- To explore the role of peroxisome proliferator-activated receptors (PPARs)/peroxisome proliferator-activated receptor gamma co-activator 1α (PGC-1α) pathways in modulating cancer cell metabolism and behavior.
Main Methods:
- Induced mitochondrial biogenesis in transformed cells using bezafibrate, a PPARs panagonist.
- Activated the PPARs/PGC-1α pathways to increase mitochondrial proteins and enzyme functions.
- Assessed changes in cell growth rates, invasiveness, lactate levels, respiratory coupling, and ATP production.
Main Results:
- Bezafibrate treatment increased mitochondrial markers and enzyme functions.
- Cells with enhanced mitochondrial biogenesis exhibited decreased growth rates and reduced invasiveness, linked to lower lactate levels.
- While total respiration remained unchanged, respiratory coupling and ATP levels were significantly improved.
Conclusions:
- Increasing mitochondrial biogenesis and oxidative phosphorylation efficiency can hinder cancer progression.
- Targeting mitochondrial pathways offers a potential strategy to decrease cancer cell proliferation and invasiveness.
More Related Videos
07:58An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
Published on: May 12, 2020
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:37Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:45Mitochondrial Membranes
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...